Clinical Trials

44 enrolled 18 charts

Prostatic Neoplasms

NCT00108732 2015-06-30

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

50 enrolled 7 charts

Prostatic Neoplasms

NCT00020254 2015-04-29

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Prostatic Neoplasms

NCT00006240 2015-04-28

Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00217373 2015-04-20

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Phase 1 Completed

33 enrolled

Adult Solid Neoplasm

NCT00089063 2015-04-15

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

40 enrolled

Uveal Melanoma, Melanoma

NCT00179309 2014-07-15

Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

48 enrolled 11 charts

Breast

Breast Neoplasms

NCT00088933 2014-03-31

Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer

Phase 1 Terminated

60 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Rectal Neoplasms, Small Cell Lung Carcinoma

NCT00002817 2014-01-10

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1/2 Unknown

30 enrolled

Melanoma

NCT00258336 2014-01-10

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2 Unknown

56 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00436930 2014-01-10

Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma

200 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Melanoma

NCT00003163 2014-01-06

Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers

Phase 2 Unknown

10 enrolled

Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT00454168 2014-01-06

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

Phase 3 Unknown

244 enrolled

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00002599 2013-12-19

Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

Phase 3 Unknown

750 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00002780 2013-12-19

Biological Therapy in Treating Women With Metastatic Breast Cancer

Phase 1/2 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Phase 1 Unknown

30 enrolled

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

NCT00071955 2013-12-19

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00037037 2013-12-18

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00324831 2013-12-18

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Phase 3 Suspended

480 enrolled

Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00436761 2013-12-18

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Phase 1 Unknown

20 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00003181 2013-12-04

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Phase 2 Unknown

35 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003185 2013-12-04

Biological Therapy in Treating Patients With Glioblastoma Multiforme

40 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003490 2013-12-04

Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma